Andreas Kuhn
Management
BioNTech
Germany
Biography
Andreas Kuhn has worked in the field of RNA biochemistry and molecular biology for more than twenty years. His work on RNA-based immunotherapies began in 2007 with Ugur Sahin, and Andreas joined BioNTech RNA Pharmaceuticals GmbH (former Ribological GmbH) shortly after its founding. His main focus is expanding Ribological® proprietary technologies to increase the efficacy of RNA immunotherapies and to optimize GMP-compatible manufacturing processes for RNA. He has co-authored several publications and patents ranging from basic research on RNA to its application as a diagnostic and therapeutic agent.
Research Interest
Molecular Biology
